FDA says Addall supplements contained undeclared stimulant-like ingredients
Testing found DMAA, DMHA and phenibut across two products; only one was voluntarily recalled.
Anecdotal editorial image
The answer first
The FDA says Addall XR Shot and Addall XL capsules contained unlawful or undeclared ingredients. The company agreed to recall the shot but declined to recall the capsules, according to the April update.
Why it matters
The case shows why a supplement label may not reflect the actual pharmacological exposure—and why a voluntary recall can cover only part of a warning.
What testing found
FDA laboratory testing found undeclared 1,4-DMAA in both products. The shot also contained phenibut, which the agency says is not a lawful dietary-supplement ingredient, while the capsules contained DMHA.
The FDA describes cardiovascular and neurocognitive concerns associated with the ingredients and says the firm declined to recall the capsule product.
How to use the warning
This is a named-product alert, not a general statement about all energy or focus supplements. Consumers should use the FDA page for current product images and instructions because those details can change.
The broader signal is that stimulant-style supplement categories deserve ingredient-level scrutiny, particularly when marketing resembles prescription or illicit-drug effects.
Product-specific safety alert from the FDA.
Primary sources
Check the underlying record.
- 01FDA Advises Consumers Not to Eat, Sell, or Distribute Addall XR Shot or Addall XLregulator
US Food and Drug Administration · 2026-04-03
Keep following the change
Get the most material safety & regulation updates in the free Anecdotal Briefing.
We never sell or share your email. Unsubscribe in one click.
Keep reading
Related intelligence.
The US moringa-powder Salmonella outbreak is over—but recalled products may remain
The FDA and CDC closed the investigation after 131 reported cases across 38 states. The products have long shelf lives.
FDA expands its import alert for supplements containing undeclared drug ingredients
The July update covers products marketed for sexual enhancement, weight loss, muscle building and other uses.
The UK has rewritten its consumer guide to food supplements
The June guidance explains authorised claims, interactions and why supplement labels cannot promise to treat symptoms.